Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249923 · ClinicalTrials.gov registry record
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
A clinical trial of Pulmonary Arterial Hypertension and Pulmonary Vascular Disease, sponsored by New York Medical College.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 14
- Study locations
NCT02249923: Recruiting study of Pulmonary Arterial Hypertension and Pulmonary Vascular Disease, sponsored by New York Medical College.
NCT02249923 is a study of Pulmonary Arterial Hypertension and Pulmonary Vascular Disease that is actively recruiting participants, run by New York Medical College. The registered enrollment target is 2,500 participants, above the 423-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (491% higher). The trial reports 14 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02249923, a study of Pulmonary Arterial Hypertension and Pulmonary Vascular Disease, is actively recruiting participants, sponsored by New York Medical College.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 14
- Study locations
Study Summary
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.
Primary Outcome
Time to clinical worsening for death, cardiac transplant, atrial septostomy, or Potts shunt.
Conditions Studied
Study Locations (14)
California
- Stanford University Medical Center - Palo Alto
- University California San Francisco - San Francisco
New York
- Columbia University Medical Center - New York
- Maria Fareri Children's Hospital at WMC Health/Westchester Medical Center - New York
Colorado
- Children's Hospital Colorado - Aurora
Florida
- Johns Hopkins All Children's Heart Institute - St. Petersburg
Maryland
- Johns Hopkins Children's Center - Baltimore
Massachusetts
- Boston Children's Hospital - Boston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2014-10 |
| Est. Completion | 2031-12 |
What NCT02249923 shows while recruiting
NCT02249923 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 423-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (491% higher).
The record links to 2 conditions, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT02249923 lists 14 locations in 12 states (California, New York, Colorado).
Frequently Asked Questions
What is clinical trial NCT02249923 about?
NCT02249923 is a clinical study titled "Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry". Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe th...
What is the current status of trial NCT02249923?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2014-10. Estimated completion is 2031-12.
What conditions does trial NCT02249923 study?
This clinical trial studies the following conditions: Pulmonary Arterial Hypertension, Pulmonary Vascular Disease.
Who is sponsoring clinical trial NCT02249923?
This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02249923 being conducted?
This trial has 14 study locations across California, Colorado, Florida, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Arterial Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02249923's enrollment target sits among peer trials
2,500 4th of 63 higher than 60 of 63 other Pulmonary Arterial Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Arterial Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
RECRUITING · NA
-
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
RECRUITING · Phase 3
-
A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension
RECRUITING · Phase 1
-
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
RECRUITING · Phase 2
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia